It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2015.
2015 | Chennai, Tamil Nadu, India | ActiveMiddle Mist Pharmaceuticals Private Limited, a active private limited company, was established on 05 August 2015 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33100TN2015PTC101687. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.71 Cr.
It upholds a compliant status. Employing 21 professional, Its leadership includes Kuppusamy Ramadas (Whole-Time Director), Rakesh Sharma Devarajan (Whole-Time Director). It holds ₹2.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Door No.1/230, Leelavathi Nagar, Kundrathur Main Road, Chikarayapuram, Chennai, Tamil Nadu, 600069.
U33100TN2015PTC101687
101687
05 August 2015
₹5.00 Cr
₹4.71 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Middle Mist Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kuppusamy Ramadas | Whole-Time Director | 05 Aug 2015 | Current |
| Rakesh Sharma Devarajan | Whole-Time Director | 05 Aug 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Middle Mist Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.1% increase. The company also saw a substantial improvement in profitability, with a 43.13% increase in profit. The company's net worth Soared by an impressive increase of 40.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Middle Mist Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2024 | Others | ₹2.00 Cr | Open |
| 02 May 2022 | Axis Bank Limited | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Middle Mist Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Middle Mist Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Middle Mist Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Middle Mist Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Middle Mist Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100882587 was registered on 17 Jan 2024. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 0.25 Cr with Charge ID 100572081 was registered on 02 May 2022. was completed.
Kuppusamy Ramadas was appointed as a Whole-time director was appointed as a Whole-time director on 05 Aug 2015 & has been associated with this company since 10 years 3 months . was recorded as a recent event.
The activity Rakesh Sharma Devarajan was appointed as a Whole-time director was appointed as a Whole-time director on 05 Aug 2015 & has been associated with this company since 10 years 3 months . was completed.
The CIN of Middle Mist Pharmaceuticals Private Limited is U33100TN2015PTC101687.
Middle Mist Pharmaceuticals Private Limited is headquartered at Door No.1/230, Leelavathi Nagar, Kundrathur Main Road, Chikarayapuram, Chennai, Tamil Nadu, 600069.
Middle Mist Pharmaceuticals Private Limited was incorporated on 05 August 2015.
The current directors of Middle Mist Pharmaceuticals Private Limited are
The primary industry of Middle Mist Pharmaceuticals Private Limited is Manufacturing.
Middle Mist Pharmaceuticals Private Limited is unlisted.
The authorized capital of Middle Mist Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.71 Cr.
The compliance status of Middle Mist Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX